GlassScriptPhysician profile
Timothy L Hormel
NPI 1972577997
$55,233.45
in general payments reported to CMS, 2019-2025
47 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $35K · 2021: $5,513.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $31,610.00 | 2019-2021 | |
| Allergan, INC. | $16,255.52 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $2,261.46 | 2020-2021 | |
| Biogen, INC. | $570.39 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $366.83 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $301.38 | 2019-2021 | |
| Emd Serono, INC. | $245.28 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $239.04 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $203.58 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $192.80 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $188.12 | 2019-2021 | |
| Lilly USA, LLC | $186.94 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $177.44 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $175.64 | 2019-2021 | |
| Kyowa Kirin, INC. | $174.34 | 2019-2021 |
Show all 47 companies
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Hormel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.